Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (291-300 of 627) with videos related to

Pageof 63
Sort By:
Thrombosis and Haemostasis|April 7, 2017
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX studyWilliam A Parker, Deepak L Bhatt, Jayne Prats, et al.
European Heart Journal|August 30, 2011
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentKeith A A Fox, Jonathan P Piccini, Daniel Wojdyla, et al.
Journal of the American Heart Association|May 27, 2022
Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery DiseaseMichael Szarek, Connie Hess, Manesh R Patel, et al.
Journal of Cardiac Failure|April 28, 2023
Clinical and Echocardiographic Diversity Associated With Physical Fitness in the Project Baseline Health Study: Implications for Heart Failure StagingNicholas Cauwenberghs, Francois Haddad, Melissa A Daubert, et al.
Vascular Medicine (London, England)|September 13, 2021
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trialLars Norgren, Rebecca North, Iris Baumgartner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 20, 2024
Canagliflozin and iron metabolism in the CREDENCE trialAkihiko Koshino, Hiddo J L Heerspink, Niels Jongs, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
Cardiology|June 22, 2002
Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysisYochai Birnbaum, Kenneth W Mahaffey, Douglas A Criger, et al.
The American Journal of Cardiology|February 19, 2004
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial)David E Kandzari, Christopher B Granger, Maarten L Simoons, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 18, 2023
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney diseasePeter Rossing, Florian M M Baeres, George Bakris, et al.
Pageof 63

Showing results (291-300 of 627) with videos related to

Sort By:
Pageof 63
Thrombosis and Haemostasis|April 7, 2017
Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX studyWilliam A Parker, Deepak L Bhatt, Jayne Prats, et al.
European Heart Journal|August 30, 2011
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentKeith A A Fox, Jonathan P Piccini, Daniel Wojdyla, et al.
Journal of the American Heart Association|May 27, 2022
Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery DiseaseMichael Szarek, Connie Hess, Manesh R Patel, et al.
Journal of Cardiac Failure|April 28, 2023
Clinical and Echocardiographic Diversity Associated With Physical Fitness in the Project Baseline Health Study: Implications for Heart Failure StagingNicholas Cauwenberghs, Francois Haddad, Melissa A Daubert, et al.
Vascular Medicine (London, England)|September 13, 2021
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trialLars Norgren, Rebecca North, Iris Baumgartner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 20, 2024
Canagliflozin and iron metabolism in the CREDENCE trialAkihiko Koshino, Hiddo J L Heerspink, Niels Jongs, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
Cardiology|June 22, 2002
Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysisYochai Birnbaum, Kenneth W Mahaffey, Douglas A Criger, et al.
The American Journal of Cardiology|February 19, 2004
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial)David E Kandzari, Christopher B Granger, Maarten L Simoons, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 18, 2023
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney diseasePeter Rossing, Florian M M Baeres, George Bakris, et al.
Pageof 63